118 related articles for article (PubMed ID: 3165439)
21. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
Lestingi L; Bonifati V; Stocchi F; Antonozzi I; Meco G
Eur Neurol; 1992; 32(2):65-9. PubMed ID: 1563463
[TBL] [Abstract][Full Text] [Related]
22. Disposition of oral lisuride in Parkinson's disease.
Burns RS; Gopinathan G; Hümpel M; Dorow R; Calne DB
Clin Pharmacol Ther; 1984 Apr; 35(4):548-56. PubMed ID: 6705456
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of terguride following intramuscular administration in cows and goats.
Lapka R; Krejci P; Lidický J; Frühaufová M; Rezábek K
Acta Physiol Pol; 1989; 40(1):139-44. PubMed ID: 2603744
[TBL] [Abstract][Full Text] [Related]
24. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Stocchi F; Ruggieri S; Brughitta G; Agnoli A
J Neural Transm Suppl; 1986; 22():209-18. PubMed ID: 3465872
[TBL] [Abstract][Full Text] [Related]
25. Lisuride combined with levodopa in advanced Parkinson disease.
Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V
Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504
[TBL] [Abstract][Full Text] [Related]
26. Parenteral administration of lisuride in Parkinson's disease.
Luquin MR; Obeso JA; Martínez-Lage JM; Tresguerres J; Parada J; Nieuweboer B; Dorow R; Horowski R
Adv Neurol; 1987; 45():561-8. PubMed ID: 3825733
[No Abstract] [Full Text] [Related]
27. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Capria A; Attanasio A; Quatrana M; Cannata D; Fioravanti M; Stocchi F; Ruggieri S
Clin Neuropharmacol; 1989 Aug; 12(4):331-8. PubMed ID: 2804995
[TBL] [Abstract][Full Text] [Related]
28. [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
Luquín MR; Obeso JA; Vaamonde J; Martínez Lage JM
Neurologia; 1989 Sep; 4(7):229-32. PubMed ID: 2638588
[TBL] [Abstract][Full Text] [Related]
29. Lisuride in parkinsonism.
Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
[TBL] [Abstract][Full Text] [Related]
30. Psychosis and the lisuride pump.
Critchley P; Grandas Perez F; Quinn N; Coleman R; Parkes D; Marsden CD
Lancet; 1986 Aug; 2(8502):349. PubMed ID: 2874361
[No Abstract] [Full Text] [Related]
31. Bromocriptine and lisuride in Parkinson's disease.
Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
[No Abstract] [Full Text] [Related]
32. Intravenous lisuride infusion for Parkinson's disease.
Obeso JA; Martinez-Lage JM; Luquin MR; Bolio N
Ann Neurol; 1983 Aug; 14(2):252. PubMed ID: 6625541
[No Abstract] [Full Text] [Related]
33. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey.
Krause W; Hümpel M
Eur J Drug Metab Pharmacokinet; 1988; 13(3):185-94. PubMed ID: 3240764
[TBL] [Abstract][Full Text] [Related]
35. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
Piccinin GL; Piccirilli M; Rizzo PA; Agostini L
Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447
[No Abstract] [Full Text] [Related]
36. Pergolide and lisuride for Parkinson's disease.
Lieberman AN; Leibowitz M; Neophytides A; Kupersmith M; Mehl S; Kleinberg D; Serby M; Goldstein M
Lancet; 1979 Nov; 2(8152):1129-30. PubMed ID: 91856
[No Abstract] [Full Text] [Related]
37. Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease.
Obeso JA; Luquin MR; Vaamonde J; Martînez Lage JM
J Neural Transm Suppl; 1988; 27():17-25. PubMed ID: 2969951
[TBL] [Abstract][Full Text] [Related]
38. Lisuride and pergolide in Parkinson's disease.
Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D
Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769
[No Abstract] [Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
Krause W; Sauerbrey N; Gräf KJ
Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
[TBL] [Abstract][Full Text] [Related]
40. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Obeso JA; Luquin MR; Martínez Lage JM
Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
